Arnold Baars

2.9k total citations
23 papers, 592 citations indexed

About

Arnold Baars is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Arnold Baars has authored 23 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Arnold Baars's work include Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Arnold Baars is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Arnold Baars collaborates with scholars based in Netherlands, United States and Belgium. Arnold Baars's co-authors include Rik J. Scheper, Alfons J.M. van den Eertwegh, Tanja D. de Gruijl, Paul A.M. van Leeuwen, Barbara G. Molenkamp, Berbel J.R. Sluijter, Chris J.L.M. Meijer, S. Marieke van Ham, Pepijn G.J.T.B. Wijnands and Sybren Meijer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Arnold Baars

21 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arnold Baars Netherlands	11	363	356	189	53	47	23	592
Jennifer S. Childs United States	14	529 1.5×	581 1.6×	232 1.2×	48 0.9×	47 1.0×	46	812
Dmitrij Ostroumov Germany	5	337 0.9×	294 0.8×	137 0.7×	63 1.2×	60 1.3×	6	526
Ilia N. Buhtoiarov United States	15	409 1.1×	614 1.7×	164 0.9×	30 0.6×	36 0.8×	30	812
Rinke Bos Netherlands	8	434 1.2×	541 1.5×	158 0.8×	27 0.5×	29 0.6×	15	737
Koen A. Marijt Netherlands	10	408 1.1×	480 1.3×	151 0.8×	52 1.0×	74 1.6×	13	672
Fumihiro Fujiki Japan	15	281 0.8×	292 0.8×	320 1.7×	34 0.6×	45 1.0×	42	580
Sjoerd van der Burg Netherlands	9	397 1.1×	409 1.1×	123 0.7×	24 0.5×	63 1.3×	16	581
Jimin Son South Korea	8	209 0.6×	277 0.8×	101 0.5×	55 1.0×	40 0.9×	14	438
Yiming Li China	14	298 0.8×	205 0.6×	166 0.9×	95 1.8×	93 2.0×	33	512
Henning Zelba Germany	14	594 1.6×	650 1.8×	180 1.0×	56 1.1×	53 1.1×	23	883

Countries citing papers authored by Arnold Baars

Since Specialization

Citations

This map shows the geographic impact of Arnold Baars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold Baars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold Baars more than expected).

Fields of papers citing papers by Arnold Baars

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnold Baars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold Baars. The network helps show where Arnold Baars may publish in the future.

Co-authorship network of co-authors of Arnold Baars

This figure shows the co-authorship network connecting the top 25 collaborators of Arnold Baars. A scholar is included among the top collaborators of Arnold Baars based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnold Baars. Arnold Baars is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brom, Linda, Arnold Baars, Jean‐Paul van Basten, et al.. (2024). Open communication between patients and relatives about illness & death in advanced cancer—results of the eQuiPe Study. Supportive Care in Cancer. 32(4). 214–214. 3 indexed citations

López‐Yurda, Marta, Arnold Baars, Helga Droogendijk, et al.. (2024). 596P Dose-individualisation of fluoropyrimidines in DPYD wild-type patients: Final results from the Alpe2U study. Annals of Oncology. 35. S478–S479.

Ziemons, Janine, Romy Aarnoutse, Judith de Vos‐Geelen, et al.. (2023). Fecal levels of SCFA and BCFA during capecitabine in patients with metastatic or unresectable colorectal cancer. Clinical and Experimental Medicine. 23(7). 3919–3933. 8 indexed citations

Liefers, Gerrit‐Jan, Sanne B. Schagen, Chris Hinnen, et al.. (2023). DIRECT2: A randomized phase III trial with a fasting mimicking diet program to improve chemotherapy in patients with hormone receptor positive, HER2-negative breast cancer—A Dutch Breast Cancer Research Group study (BOOG).. Journal of Clinical Oncology. 41(16_suppl). TPS630–TPS630.

Raijmakers, Natasja, Arnold Baars, M.H.J. van den Beuken-van Everdingen, et al.. (2023). Trajectories of health‐related quality of life and symptom burden in patients with advanced cancer towards the end of life: Longitudinal results from the eQuiPe study. Cancer. 130(4). 609–617. 18 indexed citations

Punt, Cornelis J.A., Johannes J.M. Kwakman, Linda Mol, et al.. (2022). Long-Term Safety Data on S-1 Administered After Previous Intolerance to Capecitabine-Containing Systemic Treatment for Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 21(3). 229–235. 4 indexed citations

Aarnoutse, Romy, Janine Ziemons, Judith de Vos‐Geelen, et al.. (2021). The Role of Intestinal Microbiota in Metastatic Colorectal Cancer Patients Treated With Capecitabine. Clinical Colorectal Cancer. 21(2). e87–e97. 10 indexed citations

Koster, Bas D., Saskia J. Santegoets, Arnold Baars, et al.. (2019). Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial. Cancer Immunology Immunotherapy. 68(6). 1025–1035. 19 indexed citations

Koster, Bas D., Mari F.C.M. van den Hout, Berbel J.R. Sluijter, et al.. (2017). Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I–II Melanoma: Data from Two Randomized Phase II Trials. Clinical Cancer Research. 23(19). 5679–5686. 54 indexed citations

10.

Kwakman, Johannes J.M., Geraldine R. Vink, Laurens V. Beerepoot, et al.. (2017). Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands. International Journal of Clinical Oncology. 23(3). 482–489. 27 indexed citations

11.

Kwakman, R., Arnold Baars, Henk Boot, et al.. (2017). Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in Western cancer patients. European Journal of Cancer. 72. S69–S69. 1 indexed citations

12.

Roodhart, Jeanine M.L., Marlies H.G. Langenberg, Joost S.P. Vermaat, et al.. (2010). Late Release of Circulating Endothelial Cells and Endothelial Progenitor Cells after Chemotherapy Predicts Response and Survival in Cancer Patients. Neoplasia. 12(1). 87–94. 63 indexed citations

13.

Molenkamp, Barbara G., Paul A.M. van Leeuwen, Sybren Meijer, et al.. (2007). Intradermal CpG-B Activates Both Plasmacytoid and Myeloid Dendritic Cells in the Sentinel Lymph Node of Melanoma Patients. Clinical Cancer Research. 13(10). 2961–2969. 96 indexed citations

14.

Haanen, John B.A.G., Arnold Baars, Raquel Gomez, et al.. (2005). Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients. Cancer Immunology Immunotherapy. 55(4). 451–458. 106 indexed citations

15.

Houdt, Inge S. van, Joost J. Oudejans, Alfonsus Johannes Maria van den Eertwegh, et al.. (2005). Expression of the Apoptosis Inhibitor Protease Inhibitor 9 Predicts Clinical Outcome in Vaccinated Patients with Stage III and IV Melanoma. Clinical Cancer Research. 11(17). 6400–6407. 74 indexed citations

16.

Baars, Arnold & Richard T. Timmer. (2002). Tourism development and contested communities: the issue of Belfast, Northern Ireland. PubMed. 146(19). 906–9. 4 indexed citations

17.

Baars, Arnold, A.M.E. Claessen, John Wagstaff, et al.. (2002). A phase II study of active specific immunotherapy and5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma. British Journal of Cancer. 86(8). 1230–1234. 21 indexed citations

18.

Baars, Arnold, Jan Buter, & Herbert M. Pinedo. (2002). Making use of the primary tumour. BioEssays. 25(1). 79–86. 5 indexed citations

19.

Baars, Arnold, et al.. (2001). Adjuvant Treatment of Colorectal Cancer: Towards Tumor-specific Immunotherapies. Cancer and Metastasis Reviews. 20(1-2). 101–108. 4 indexed citations

20.

Baars, Arnold, A.M.E. Claessen, H.E. Gall, et al.. (2000). Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: Experience in 81 patients. Annals of Oncology. 11(8). 965–970. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact